We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scapa Group Plc | LSE:SCPA | London | Ordinary Share | GB0007281198 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 214.50 | 214.50 | 215.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSCPA
RNS Number : 4740G
Scapa Group PLC
23 July 2019
23 July 2019
LEI No. 213800QIPVTK5ES5UU36
Scapa Group plc
('Scapa' or 'the Company')
Result of AGM
Scapa Group plc (AIM: SCPA) is pleased to announce that all resolutions proposed at its Annual General Meeting held on 23 July 2019 were duly passed by shareholders on a poll. The poll votes on each resolution proposed are set out below:-
Resolution For Against Withheld 1 To receive the Accounts and Reports of the Directors and Auditors for the year ended 31 March 2019 100,106,116 0 76,750 100%* 0.00%* ------------ ----------- ---------- 2 To approve the Directors' Remuneration Report (excluding the Directors' Remuneration Policy) for the financial year ended 31 March 2019. 85,747,141 14,131,980 303,745 85.85%* 14.15%* ------------ ----------- ---------- 3 To approve the Directors' Remuneration Policy for the financial year ended 31 March 2019. 98,390,796 1,787,365 4,705 98.22%* 1.78%* ------------ ----------- ---------- 4 To declare a final dividend of 2.9p per ordinary share 100,180,981 0 1,885 100%* 0.00%* ------------ ----------- ---------- 5 To re-elect Larry Pentz as a Director 98,349,198 864,689 968,979 99.13%* 0.87%* ------------ ----------- ---------- 6 To re-elect Heejae Chae as a Director 100,016,778 162,703 3,385 99.84%* 0.16%* ------------ ----------- ---------- 7 To re-elect David Blackwood as a Director 99,900,151 279,330 3,385 99.72%* 0.28%* ------------ ----------- ---------- 8 To re-elect Pierre Guyot as a Director 99,915,069 264,412 3,385 99.74%* 0.26%* ------------ ----------- ---------- 9 To re-elect Brendan McAtamney as a Director 99,915,069 264,412 3,385 99.74%* 0.26%* ------------ ----------- ---------- 10 To elect Oskar Zahn as a Director 99,562,291 618,704 1,871 99.38%* 0.62%* ------------ ----------- ---------- 11 To elect Sevan Demirdogen as a Director 100,018,292 162,703 1,871 99.84%* 0.16%* ------------ ----------- ---------- 12 To elect Joseph Doherty as a Director 100,018,292 162,703 1,871 99.84%* 0.16%* ------------ ----------- ---------- 13 RESOLUTION WITHDRAWN 14 To reappoint Deloitte LLP as auditor of the Company 99,273,495 607,140 302,231 99.39%* 0.61%* ------------ ----------- ---------- 15 To authorise the Directors to fix the remuneration of the auditor 100,107,256 74,879 731 99.93%* 0.07%* ------------ ----------- ---------- 16 That the rules of the Scapa Group plc 2019 Long Term Incentive Plan are approved 98,502,321 1,678,685 1,860 98.32%* 1.68%* ------------ ----------- ---------- 17 To authorise the Company to make political donations 98,529,711 1,651,295 1,860 98.35%* 1.65%* ------------ ----------- ---------- 18 To authorise the Directors to allot shares 93,047,128 7,128,878 6,860 92.88%* 7.12%* ------------ ----------- ---------- 19 To authorise the Directors to dis-apply pre-emption rights in relation to the customary 5% power pursuant to the statement of principles dis-applying pre-emption rights 100,174,274 1,361 7,231 100%* 0.00%* ------------ ----------- ---------- 20 To authorise the Directors to dis-apply pre-emption rights in relation to the additional 5% power to be used in connection with an acquisition or a specified capital investment 99,288,893 885,782 8,191 99.12%* 0.88%* ------------ ----------- ---------- 21 To authorise the Company to make market purchases of its own shares 99,867,159 300,401 15,306 99.70%* 0.30%* ------------ ----------- ----------
* as a percentage of votes cast
For further information:
Scapa Group plc: Wendy Baker Company Secretary +44 (0) 161 301 7400 Numis Securities Limited: Mark Lander/Richard Thomas (Joint Broker/Nominated Adviser) +44 (0) 20 7260 1000
About Scapa Group plc
Scapa Group plc is a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers.
Healthcare
Scapa Healthcare is the trusted strategic partner of choice for the world's leading companies in Advanced Wound Care, Consumer Wellness and Medical Device Fixation. We partner with the top global MedTech companies to develop and manufacture innovative skin friendly medical device fixation and topical solutions, from inception through to market delivery, from our state-of-the-art facilities.
For further information, please visit www.scapahealthcare.com
Industrial
Scapa Industrial is a global supplier of bonding solutions and manufacturer of adhesive-based products which offer meaningful value in industrial applications due to their lightweight, easy-to-apply properties. We are recognised for our unparalleled range of products, including adhesive tapes, films and foams, and we can engineer custom designs for even the most unique applications.
For further information, please visit www.scapaindustrial.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGPGUMWMUPBGAW
(END) Dow Jones Newswires
July 23, 2019 11:39 ET (15:39 GMT)
1 Year Scapa Chart |
1 Month Scapa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions